| Oxytetracycline |

Last updated: 25/02/2026
|
 |
(Also known as: terramycin; oxytracyl; oxytetrin; terramitsin; oxitetracycline; crop antibiotic; liquamycin) |
The following Pesticide Hazard Tricolour (PHT) alerts are based on the data in the tables below. An absence of an alert does not imply the substance has no implications for human health, biodiversity or the environment but just that we do not have the data to form a judgement. The alerts for Highly Hazardous Pesticides (HHPs) are based on applying the FAO/WHO (Type 1) and the PAN (Type II) criteria to PPDB data. Further details on the HHP indicators are given in the tables below. Neither the PHT nor the HHP hazard alerts take account of usage patterns or exposure, thus they do not represent risk.
| PHT: Environmental fate |
PHT: Ecotoxicity |
PHT: Human health |
Highly Hazardous Pesticide |
|   |
|
|
|
|
|
A bactericide, usually used as the hydrochloride, for the control of bacteria, fungi and mycoplasma-like organisms in fruit and turf. It is also used in veterinary products and for aquaculture |
|
|
Bacterial diseases including fireblight and those caused by Pseudomonas spp. and Xanthomonas spp. |
|
|
Top fruit; Stone fruit; Turf |
|
|
- |
|
|
- |
|
|
- |
|
|
Not approved |
|
|
Not applicable |
|
|
No UK approval for use as a plant protection agent |
| EC Regulation 1107/2009 (repealing 91/414) |
|
|
Not approved |
|
|
Not applicable |
|
|
Not applicable |
|
|
- |
|
|
Yes |
|
|
ATAustria |
BEBelgium |
BGBulgaria |
CYCyprus |
CZCzech Republic |
DEGermany |
DKDenmark |
EEEstonia |
ELGreece |
|   |
  |
  |
  |
  |
  |
  |
  |
  |
ESSpain |
FIFinland |
FRFrance |
HRCroatia |
HUHungary |
IEIreland |
ITItaly |
LTLithuania |
LULuxembourg |
|   |
  |
  |
  |
  |
  |
  |
  |
  |
LVLatvia |
MTMalta |
NLNetherlands |
PLPoland |
PTPortugal |
RORomania |
SESweden |
SISlovenia |
SKSlovakia |
|   |
  |
  |
  |
  |
  |
  |
  |
  |
|
|
|
ISIceland |
NONorway |
|
|
|
|
|
|
|
|   |
  |
  |
  |
  |
  |
  |
  |
  |
|
|
|
Northern Ireland; Australia; Japan |
|
|
Oxytetracycline exhibits complex stereoisomerism, with six chiral centres in its molecular structure, allowing for multiple stereoisomers. These chiral centres are located at carbon atoms 4, 4a, 5, 5a, 6, and 12a, and their configuration significantly influences the compound’s biological activity and chemical behaviour. Additionally, oxytetracycline can undergo tautomerization and epimerization, especially under varying pH conditions, leading to the formation of inactive derivatives such as anhydrotetracyclines and isotetracyclines. These transformations affect its stability and efficacy, making isomerism a critical factor in its environmental fate. |
|
|
C₂₂H₂₄N₂O₉ |
|
|
CC1(C2C(C3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O)O |
|
|
C[C@@]1([C@H]2[C@@H]([C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O)O |
|
|
IWVCMVBTMGNXQD-PXOLEDIWSA-N |
|
|
InChI=1S/C22H24N2O9/c1-21(32)7-5-4-6-8(25)9(7)15(26)10-12(21)17(28)13-14(24(2)3)16(27)11(20(23)31)19(30)22(13,33)18(10)29/h4-6,12-14,17,25,27-29,32-33H,1-3H3,(H2,23,31)/t12-,13-,14+,17+,21-,22+/m1/s1 |
|
|
Yes |
| Cambridge Crystallographic Data Centre diagrams |
|
|
| Common Name |
Relationship |
Link |
| oxytetracycline |
- |
 |
|
|
Veterinary substance; Crop antibiotic; Other substance |
|
|
Antimicrobial |
|
|
Micro-organism derived substance |
|
|
- |
|
|
- |
|
|
Natural |
|
|
Broad-spectrum, protein synthesis inhibitor and binds to the 30S and 50S bacterial ribosomal subunits |
|
|
Substance produced by the fermentation of Streptomyces rimosus |
|
|
Crop protection |
|
|
Bacterial diseases including fireblight and those caused by Pseudomonas spp. and Xanthomonas spp. |
|
|
Top fruit; Stone fruit; Turf |
|
|
- |
|
|
79-57-2 |
|
|
2058-46-0; 6153-64-6 (dihydrate) |
|
|
201-212-8 |
|
|
316 |
|
|
006308 |
|
|
- |
|
|
460.44 |
|
|
- |
|
|
(4S,4aR,5S,5aR,6S,12aS)-4-dimethylamino-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxonaphthacene-2-carboxamide |
|
|
(4S,4aR,5S,5aR,6S,12aS)-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide |
|
|
| UK Poisons List Order 1972 |
Rotterdam Convention |
Montreal Protocol |
|
|
|
| Stockholm Convention |
OSPAR |
EU Water Framework Directive |
|
|
|
|
|
|
- |
|
|
- |
|
|
|
Yes [ C4 Criterion 4: Pesticide active ingredients that meet the criteria of reproductive toxicity Categories 1A and 1B of the Globally Harmonized System on Classification and Labelling of Chemicals (GHS) (those with a CLP classification of H360) ] |
|
|
Yes [ R04 Rule 4: Pesticide active ingredients that meet the criteria of reproductive toxicity Categories 1A and 1B of the Globally Harmonized System on Classification and Labelling of Chemicals (GHS) (those with a CLP classification of H360) ] |
|
|
Possible groundwater contaminant |
|
|
Not applicable |
|
|
Not applicable |
|
|
Not applicable |
|
|
41 |
|
|
- |
|
|
Pale yellow to tan coloured crystalline powder |
|
|
|
|
|
|
|
|
Current |
|
|
1974, first registered USA |
|
|
- Syngenta AG
- Ladda
- Norbrook Laboratories Ltd
- MSD Animal Health UK Ltd
- Huvepharma SA
|
|
|
- Mycoshield
- Cuprimicina Agrıcola
- Cuprimicın
- Mycoject
- Phytomycin
- Alamycin Solution for Injection
- Hypersol Powder for Drinking Water
|
|
|
Supplied as a water soluble powder for preparation as injection or as a liquid concentrate when used as a veterinary product. For crop protection it is used as a foliar spray |
|
|
Oxytetracycline is produced commercially through a fermentation process using the bacterium Streptomyces rimosus. The production strain, typically a hyperproducing mutant of the bacterium, is selected and optimised through mutagenesis and selection techniques to enhance yield. The selected strain is cultivated in large fermenters in a small volume of nutrient-rich medium to increase their biomass. The biomass is then transferred to larger fermenters containing a production medium optimised for oxytetracycline synthesis. During fermentation, the bacteria produce oxytetracycline through a complex biosynthetic pathway involving polyketide synthase enzymes. After the fermentation is complete, the oxytetracycline is extracted from the culture broth. This involves several steps, including filtration, solvent extraction, and crystallization, to purify the oxytetracycline which is then formulated, usually as the hydrochloride salt. |
|
|
Published GHG data is not available for most pharmaceuticals. However, according to industry, global averages suggest producing 1 kg of a typical active pharmaceutical ingredient can range from 10 to 100 kg CO₂e for small molecule drugs and potentially up to 1000 kg CO₂e for complex biologicals such as vaccines, depending on the drug type, its formulation, complexity of synthesis, solvent recovery, and energy sources used. |
|
|
|
|
|
|
|
|
|
|
600 |
|
Moderate |
|
|
- |
- |
- |
|
|
Decomposes on melting |
|
- |
|
|
- |
- |
- |
|
|
179 |
|
- |
|
|
- |
- |
- |
|
|
|
- |
- |
- |
|
|
- |
- |
- |
|
|
|
- |
- |
- |
|
|
- |
- |
- |
|
|
- |
- |
- |
|
|
- |
- |
- |
| - |
|
|
- |
- |
- |
|
|
- |
- |
- |
|
|
|
- |
- |
- |
|
|
- |
- |
- |
|
|
- |
- |
- |
|
|
- |
- |
- |
|
|
|
|
|
|
|
- |
|
|
|
- |
- |
- |
|
|
- |
- |
- |
|
|
- |
- |
- |
|
|
- |
- |
- |
|
|
- |
- |
- |
|
|
- |
- |
- |
|
|
- |
|
|
|
- |
- |
- |
|
|
- |
|
|
|
8.2 |
R4 R = Peer reviewed scientific publications 4 = Verified data |
- |
|
|
Brussel sprouts undercover |
|
|
|
- |
- |
- |
|
|
- |
|
|
|
- |
- |
- |
|
|
- |
|
|
- |
- |
- |
|
|
- |
- |
- |
|
|
- |
- |
- |
|
|
As this parameter is not normally measured directly, a surrogate measure is used: ‘Photochemical oxidative DT₅₀’. Where data is available, this can be found in the Fate Indices section below. |
|
|
- |
| Soil adsorption and mobility |
|
None
| Terrestrial ecotoxicology |
|
|
|
|
|
|
|
7200 |
Mouse |
Low |
|
|
- |
- |
- |
|
|
- |
- |
- |
|
|
> 5620 |
Anas platyrhynchos as HCl variant |
Low |
|
|
- |
- |
- |
|
|
- |
- |
- |
|
|
1954 |
R3 R = Peer reviewed scientific publications 3 = Unverified data of known source as HCl variant |
Low |
|
|
- |
- |
- |
|
|
- |
- |
- |
|
|
|
- |
- |
- |
|
|
- |
- |
- |
|
|
|
- |
- |
- |
|
|
- |
- |
- |
|
|
|
- |
- |
- |
|
|
- |
- |
- |
|
|
100 |
as HCl variant |
Moderate |
|
|
- |
- |
- |
|
|
- |
|
|
|
- |
- |
- |
| - |
|
|
- |
- |
- |
| - |
|
|
|
- |
- |
- |
|
|
- |
- |
- |
|
|
|
- |
- |
- |
|
|
- |
|
|
|
- |
- |
- |
|
|
- |
|
|
- |
- |
- |
|
|
- |
- |
- |
|
|
- |
- |
- |
|
|
- |
- |
- |
|
|
- |
- |
- |
|
|
|
- |
- |
- |
|
|
- |
|
- |
- |
- |
|
|
- |
|
|
|
|
|
|
|
116 |
Oncorhynchus mykiss as HCl variant |
Low |
|
|
- |
- |
- |
|
|
- |
- |
- |
|
|
102 |
Daphnia magna as HCl variant |
Low |
|
|
46.2 |
R3 R = Peer reviewed scientific publications 3 = Unverified data of known source Daphnia magna as HCl variant |
Low |
|
|
- |
- |
- |
|
|
- |
- |
- |
|
|
- |
- |
- |
|
|
- |
- |
- |
|
|
- |
- |
- |
|
|
- |
- |
- |
|
|
- |
- |
- |
|
|
0.372 |
R3 R = Peer reviewed scientific publications 3 = Unverified data of known source Raphidocelis subcapitata as HCl variant |
Moderate |
|
|
0.183 |
R3 R = Peer reviewed scientific publications 3 = Unverified data of known source Raphidocelis subcapitata as HCl variant |
Moderate |
|
|
|
- |
- |
- |
|
- |
- |
- |
|
|
- |
- |
- |
| Regulatory Threshold Levels (RTLs) |
|
Note: These RTLs have been calculated using the regulatory approach used in the European Union and based on ecotoxocity values in the PPDB.
|
|
|
|
|
|
720 |
Worst case of acute and chronic mammals |
|
|
562 |
Worst case of acute and chronic birds |
|
|
390.8 |
Worst case of acute and chronic earthworms |
|
|
No data |
No data for non-target plants vegetative vigour and seedling emergence |
|
|
No data |
No data for contact and oral honeybees |
|
|
No data |
No data for parasitic wasps and predatory mites |
|
|
1.16 |
Worst case of temperate acute and chronic fish |
|
|
1.02 |
Worst case of temperate acute and chronic aquatic invertebrates |
|
|
0.0183 |
Worst case of free-floating plants, rooted plants, acute and chronic algae |
| HUMAN HEALTH AND PROTECTION |
|
|
|
|
|
|
|
|
|
High (class III) |
- |
- |
|
|
7200 |
Mouse |
Low |
|
|
- |
- |
- |
|
|
- |
- |
- |
|
|
- |
- |
- |
|
|
- |
- |
- |
|
|
- |
- |
- |
|
|
- |
- |
- |
|
|
- |
- |
- |
|
|
- |
- |
- |
|
|
- |
- |
- |
|
|
- |
- |
- |
|
|
- |
- |
- |
|
|
|
- |
|
|
- |
|
|
Systemically available oxytetracycline was primarily excreted in the urine and bile |
Q3 Q = Miscellaneous data from online sources 3 = Unverified data of known source |
- |
|
|
| Carcinogen |
|
Endocrine disruptor |
XNo, known not to cause a problem |
A0 A = Chromosome aberration (EFSA database) 0 = No data ; B0 B = DNA damage/repair (EFSA database) 0 = No data ; C0 C = Gene mutation (EFSA database) 0 = No data ; D0 D = Genome mutation (EFSA database) 0 = No data ; E0 E = Unspecified genotoxicity type (miscellaneous data source) 0 = No data |
No data found |
| Reproduction / development effects |
Acetyl cholinesterase inhibitor |
Neurotoxicant |
✓Yes, known to cause a problem |
XNo, known not to cause a problem |
XNo, known not to cause a problem |
| Respiratory tract irritant |
Skin irritant |
Skin sensitiser |
XNo, known not to cause a problem |
✓Yes, known to cause a problem |
✓Yes, known to cause a problem |
| Eye irritant |
Phototoxicant |
  |
✓Yes, known to cause a problem |
No data found |
  |
|
|
|
May cause hypersensitivity reactions May cause tooth discoloration |
|
|
|
|
|
No information available |
|
|
Health: H302, H312, H317, H332, H360d Environment: H400, H410 |
|
|
Not listed (Not listed) |
|
|
- |
|
|
- |
|
|
- |
|
|
|
|
|
oxytetracycline |
|
|
oxytetracycline |
|
|
Oxytetracyclin |
|
|
oxytetracyclin |
|
|
oxytetracicline |
|
|
oxitetraciclina |
|
|
- |
|
|
oksytetracyklina |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
| Record last updated: |
25/02/2026 |
| Contact: |
aeru@herts.ac.uk |
| Please cite as: |
Lewis, K.A., Tzilivakis, J., Warner, D. and Green, A. (2016) An international database for pesticide risk assessments and management. Human and Ecological Risk Assessment: An International Journal, 22(4), 1050-1064. DOI: 10.1080/10807039.2015.1133242 |
© Copyright University of Hertfordshire, 2006-2026. All Rights Reserved
Your use of this website and its various databases is subject to the terms detailed in the University of Hertfordshire’s copyright and IPR statement that can be found at
https://www.herts.ac.uk/about-us/legal.
In addition, your use of this website and its various databases is subject to the terms of this additional Copyright Statement and the database
Conditions of use document.
Unless explicitly stated otherwise, the content of this website and databases are owned and controlled by the University of Hertfordshire. Site content, including its selection and arrangement, is owned by the University of Hertfordshire and is protected by copyright and other laws.
Except as otherwise expressly permitted under copyright law or within the database Conditions of Use document, the content of this site may not be copied, reproduced, republished, downloaded, posted, broadcast or transmitted in any way without first obtaining the University of Hertfordshire’s written permission.
By using our databases the user is deemed to have agreed to comply with all of the terms and conditions as described above and within all relevant documentation.